Skip to main content
Erschienen in: Angiogenesis 3/2009

01.09.2009 | Brief Communication

Computer-aided quantification of retinal neovascularization

verfasst von: A. Stahl, K. M. Connor, P. Sapieha, K. L. Willett, N. M. Krah, R. J. Dennison, J. Chen, K. I. Guerin, L. E. H. Smith

Erschienen in: Angiogenesis | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Rodent models of retinal angiogenesis play a pivotal role in angiogenesis research. These models are a window to developmental angiogenesis, to pathological retinopathy, and are also in vivo tools for anti-angiogenic drug screening in cancer and ophthalmic research. The mouse model of oxygen-induced retinopathy (OIR) has emerged as one of the leading in vivo models for these purposes. Many of the animal studies that laid the foundation for the recent breakthrough of anti-angiogenic treatments into clinical practice were performed in the OIR model. However, readouts from the OIR model have been time-consuming and can vary depending on user experience. Here, we present a computer-aided quantification method that is characterized by (i) significantly improved efficiency, (ii) high correlation with the established hand-measurement protocols, and (iii) high intra- and inter-individual reproducibility of results. This method greatly facilitates quantification of retinal angiogenesis while at the same time increasing lab-to-lab reproducibility of one of the most widely used in vivo models in angiogenesis research.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kennedy D (2006) Breakthrough of the Year. Science : 1841 Kennedy D (2006) Breakthrough of the Year. Science : 1841
2.
Zurück zum Zitat Rosenfeld PJ et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431PubMedCrossRef Rosenfeld PJ et al (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431PubMedCrossRef
3.
Zurück zum Zitat Ranieri G et al (2006) Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem 13(16):1845–1857PubMedCrossRef Ranieri G et al (2006) Vascular endothelial growth factor (VEGF) as a target of bevacizumab in cancer: from the biology to the clinic. Curr Med Chem 13(16):1845–1857PubMedCrossRef
4.
Zurück zum Zitat Smith LE et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111PubMed Smith LE et al (1994) Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35(1):101–111PubMed
5.
Zurück zum Zitat Pierce EA et al (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92(3):905–909PubMedCrossRef Pierce EA et al (1995) Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92(3):905–909PubMedCrossRef
6.
Zurück zum Zitat Smith LE et al (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5(12):1390–1395PubMedCrossRef Smith LE et al (1999) Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 5(12):1390–1395PubMedCrossRef
7.
Zurück zum Zitat Aiello LP et al (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92(23):10457–10461PubMedCrossRef Aiello LP et al (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92(23):10457–10461PubMedCrossRef
8.
Zurück zum Zitat Bainbridge JW et al (2002) Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther 9(5):320–326PubMedCrossRef Bainbridge JW et al (2002) Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther 9(5):320–326PubMedCrossRef
9.
Zurück zum Zitat Ozaki H et al (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156(2):697–707PubMed Ozaki H et al (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 156(2):697–707PubMed
10.
Zurück zum Zitat Rota R et al (2004) Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 6(9):992–1002PubMedCrossRef Rota R et al (2004) Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer. J Gene Med 6(9):992–1002PubMedCrossRef
11.
Zurück zum Zitat Sone H et al (1999) Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci 65(24):2573–2580PubMedCrossRef Sone H et al (1999) Effects of intraocular or systemic administration of neutralizing antibody against vascular endothelial growth factor on the murine experimental model of retinopathy. Life Sci 65(24):2573–2580PubMedCrossRef
12.
Zurück zum Zitat Google scholar search 6/15/09 for “oxygen induced retinopathy mice” Google scholar search 6/15/09 for “oxygen induced retinopathy mice”
13.
Zurück zum Zitat Vanhaesebrouck S et al (2009) Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr Res 65(3):307–310PubMedCrossRef Vanhaesebrouck S et al (2009) Oxygen-induced retinopathy in mice: amplification by neonatal IGF-I deficit and attenuation by IGF-I administration. Pediatr Res 65(3):307–310PubMedCrossRef
14.
Zurück zum Zitat Higgins RD et al (1999) Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res 18(1):20–27PubMedCrossRef Higgins RD et al (1999) Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res 18(1):20–27PubMedCrossRef
15.
Zurück zum Zitat Spierer A et al (2005) An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice. Eye 19(1):86–91PubMedCrossRef Spierer A et al (2005) An increase in superoxide dismutase ameliorates oxygen-induced retinopathy in transgenic mice. Eye 19(1):86–91PubMedCrossRef
16.
Zurück zum Zitat Banin E et al (2006) T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest Ophthalmol Vis Sci 47(5):2125–2134PubMedCrossRef Banin E et al (2006) T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest Ophthalmol Vis Sci 47(5):2125–2134PubMedCrossRef
17.
Zurück zum Zitat Chen J et al (2008) Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118(2):526–533PubMed Chen J et al (2008) Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118(2):526–533PubMed
18.
Zurück zum Zitat Connor KM et al (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7):868–873PubMedCrossRef Connor KM et al (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13(7):868–873PubMedCrossRef
19.
Zurück zum Zitat Guma M et al (2009) Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. Proc Natl Acad Sci USA 106(21):8760–8765PubMedCrossRef Guma M et al (2009) Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. Proc Natl Acad Sci USA 106(21):8760–8765PubMedCrossRef
Metadaten
Titel
Computer-aided quantification of retinal neovascularization
verfasst von
A. Stahl
K. M. Connor
P. Sapieha
K. L. Willett
N. M. Krah
R. J. Dennison
J. Chen
K. I. Guerin
L. E. H. Smith
Publikationsdatum
01.09.2009
Verlag
Springer Netherlands
Erschienen in
Angiogenesis / Ausgabe 3/2009
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-009-9155-3

Weitere Artikel der Ausgabe 3/2009

Angiogenesis 3/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.